{"filing":{"accession_number":"0001801170-26-000196","cik":"0001801170","ticker":"CLOV","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"clov-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000196/clov-20260805.htm"},"events":[{"id":25257,"run_id":22918,"accession_number":"0001801170-26-000196","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release disclosing Clover Health's second quarter 2026 financial results, including GAAP Net Income of $28 million, Medicare Advantage membership of 157,309 (up 48% YoY), total revenues of $743 million (up 56% YoY), and improved full-year 2026 guidance across all metrics. The press release is furnished as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings announcements.","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","ticker":"CLOV","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":26035,"accession_number":"0001801170-26-000196","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Clover Health's second quarter 2026 financial results, including GAAP Net Income of $28 million, Medicare Advantage membership of 157,309 (up 48% YoY), total revenues of $743 million (up 56% YoY), and improved full-year 2026 guidance across all metrics. The press release is furnished as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:23:28.383723+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26035,"accession_number":"0001801170-26-000196","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Clover Health's second quarter 2026 financial results, including GAAP Net Income of $28 million, Medicare Advantage membership of 157,309 (up 48% YoY), total revenues of $743 million (up 56% YoY), and improved full-year 2026 guidance across all metrics. The press release is furnished as Exhibit 99.1 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings announcements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:23:28.383723+00:00","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","ticker":"CLOV","filing_date":"2026-08-05"}]}